J. Vestbo (Manchester, United Kingdom), J. C. Virchow (Rostock, Germany)
Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study
J. Bourbeau, J. Lee, N. Radojevic (Montreal, Canada)
|  |
Home monitoring of patients with chronic lung diseases using wireless devices
E. Meschiari, P. Cavalli, M. Rizzi, L. Fabbri, M. Moretti (Modena, Rubiera, Bologna, Italy)
| |
Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters
N. Kokturk, S. Demirtas, O. Gulbahar, G. Bozdayi, T. Tatlicioglu (Ankara, Turkey)
| |
Appropriateness of hospital stay in respiratory departments of the Spanish hospitals
E. Farrero, E. Prats, J. Escarrabill, on behalf of the VIVALDI Study Group (Barcelona, Spain)
| |
The rate of pulmonary thromboembolism in acute exacerbation of chronic obstructive pulmonary disease
S. Canbakan, E. Akinci, N. Çapan, M. Gülhan, A. Ertürk, Y. Dadali (Ankara, Turkey)
| |
Feasibility of early detection of COPD exacerbations using home inspiratory capacity monitoring
C. B. Cooper, E. C. Kleerup, M. R. Zeidler, D. P. Tashkin (Los Angeles, United States Of America)
| |
DNA microsatellite instability is associated with exacerbations in COPD
D. Makris, E. Tzortzaki, N. Tzanakis, A. Damianaki, M. Zervou, N. M. Siafakas (Heraklion, Greece)
| |
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL
R. Rozynska, K. Jahnz-Rozyk, T. Targowski, A. Chcialowski, T. Plusa (Warsaw, Poland)
| |
Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas induced COPD
M. Ghanei, M. J. Arab, A. Hosseini, M. Mojtahedzadeh, J. Aslani (Tehran, Islamic Republic Of Iran)
| |
The role of bacterial infections in COPD exacerbations
D. V. Todea, N. N. Ariesanu (Cluj-Napoca, Romania)
| |
Sick euthyroid syndrome prevalence in COPD patients with respiratory failure
S. Altin, E. C. Seyhan, K. Epozturk, E. Cetinkaya, L. Karasulu (Istanbul, Turkey)
| |
Effects of steroid treatment on hemodynamic and haemostatic parameters in COPD exacerbation
E. Kunter, A. Ilvan, A. Ozturk, E. Demirer, N. Ozmen, K. Avsar, O. Sayan (Istanbul, Turkey)
| |
Retrospective audit of dexa scan results in COPD early discharge patients
S. Kealy, M. Lawlor (Dublin, Israel)
| |
Chronic obstructive pulmonary disease (COPD) assessment service: guidelines for referral and accuracy of clinical assessment
A. C. Elliott, S. Khalid, A. Pilling, J. Wright, R. J. Wolstenholme (Wigan, United Kingdom)
| |
Evaluation of serum troponin level in exacerbation of COPD
D. Kanmaz, E. Yenturk, D. Yenibertiz, N. Alkan, Y. Alturk, B. Yilmaz, E. Tuncay (Istanbul, Turkey)
| |
The BAL in the bacteriologic etiology in the COPD exacerbations
A. Scaramozzino, G. Porcino, G. Grippaldi (Reggio Calabria, Italy)
| |
Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation
E. B. Bukreeva, S. V. Nesterovich, R. I. Pleshko, B. V. Shilov, T. G. Melnik, N. V. Shilova (Tomsk, Russian Federation)
| |
Regular basis visits and recovery of exacerbations, morbidity in patients with chronic obstructive pulmmonary disease
Z. P. Onen, E. Sen, B. Gulbay, O. Akkoca Yildiz, S. Saryal (Ankara, Turkey)
| |
Evaluation of electrocardiographic (ECG) changes in subjects with severe asthma or COPD exacerbation
J. Mazurek, J. Osmólska, R. Chazan (Warsaw, Poland)
| |
Are COPD exacerbations associated with the severity of the disease?
D. Makris, N. Tzanakis, J. Moschandrea, A. Damianaki, G. Maltezakis, E. Ntaoukakis, N. M. Siafakas (Heraklion, Chania, Greece)
| |